Company Data
Stoke Therapeutics Inc.
Ticker
STOK
Current Price
$19.48 -1.47%
Market Cap
$1.1B
Price Target
Refer to Report
Volume
270.0K
52wk Range
$5.35 - $19.97
Overview
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.